Skip to content

Ensuring the Safety of Novel Viral Vector Platforms 

Learn how we assess neurovirulence and neurotoxicity for responsible development of viral-based medicines.

The rapid development of viral vector platforms for gene therapy and vaccines holds immense potential for treating various diseases. However, as witnessed in the past, inadequate safety characterization can have devastating consequences. To ensure the safe and responsible development of these therapeutics, thorough neurovirulence and neurotoxicity testing is crucial.

Complete the form to download our white paper and learn more. 

Southern Research is a nonprofit, full-service contract research organization with 80+ years of experience in drug discovery and development. Our team of industry-leading experts provide personalized, white-glove support to our clients—including insightful project management, exceptional quality assurance, regulatory affairs guidance, and collaborative problem solving. With ABSL-2 and ABSL-3 containment, our laboratories are also equipped for studies involving pathogenic agents.

We offer competitive timelines to advance your program efficiently and effectively. We look forward to helping your company move science and build better health outcomes for all.  

TDF-Landing-Page-Icons-1-07
Expertise-icon-1
Services
Expertise
We are your collaborative contract research services leader for your drug discovery and preclinical development needs.
For the past 80 years, we have developed processes and technologies to support the discovery and development of treatments and cures for diseases.

A Proven Partner to Help Move Your Science Forward

From basic research services to advanced, GLP preclinical studies in an FDA-inspected facility, you can rely on the experts at Southern Research to support scientific discovery in a multitude of specialties.

SR-Building-Rendering-1

About Southern Research

Founded in Birmingham in 1941, Southern Research is a non-profit scientific research organization that employs 250 scientists and professional staff. In its 80-year legacy of moving science, the organization has helped shape modern cancer treatment practices, including developing seven FDA-approved cancer drugs and testing more than half of active chemotherapies in the United States.

Testimonials

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

“Add a testimonial to vouch for your services. Why are your current customers excited about what you offer?”
Ervin Howell, VP Product, Deckow-Crist
“Add a testimonial to vouch for your services. Why are your current customers excited about what you offer?”
Clementina DuBuque, SVP Sales, Hoeger LLC.
“Add a testimonial to vouch for your services. Why are your current customers excited about what you offer?”
Kurtis Weissnat, CMO, Brunlow Inc.